Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.36 USD | +0.75% | -2.86% | -49.63% |
May. 28 | Enlivex Therapeutics to Launch Registered Direct Offering; Shares Fall | MT |
Apr. 22 | Enlivex Therapeutics Says First Two Patients Dosed in Knee Osteoarthritis Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.63% | 27.79M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- ENLV Stock
- News Enlivex Therapeutics Ltd.
- Enlivex Therapeutics Receives Approval to Expand Trial of Allocetra to Treat Knee Osteoarthritis Into Denmark